Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Long-Term Deferred Tax: 2023-2024

Historic Long-Term Deferred Tax for Eton Pharmaceuticals (ETON) over the last 2 years, with Dec 2024 value amounting to $404,000.

  • Eton Pharmaceuticals' Long-Term Deferred Tax rose 139.05% to $404,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $404,000, marking a year-over-year increase of 139.05%. This contributed to the annual value of $404,000 for FY2024, which is 139.05% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Long-Term Deferred Tax stood at $404,000 for FY2024, which was up 139.05% from $169,000 recorded in FY2023.
  • Eton Pharmaceuticals' 5-year Long-Term Deferred Tax high stood at $404,000 for FY2024, and its period low was $169,000 during FY2023.
  • Over the past 2 years, Eton Pharmaceuticals' median Long-Term Deferred Tax value was $286,500 (recorded in 2023), while the average stood at $286,500.
  • Data for Eton Pharmaceuticals' Long-Term Deferred Tax shows a peak YoY soared of 139.05% (in 2024) over the last 5 years.
  • Eton Pharmaceuticals' Long-Term Deferred Tax (Yearly) stood at $169,000 in 2023, then skyrocketed by 139.05% to $404,000 in 2024.